© 2020 HealthCore Inc.
menu
Life Sciences
search
menu Life Sciences
search
Life Sciences
Life Sciences

Through our deep expertise combining prospective and retrospective data, we collaborate with you to help you overcome your challenges and achieve goals across all phases of research.

Through our deep expertise combining prospective and retrospective data, we collaborate with you to help you overcome your challenges and achieve goals across all phases of research.

WHAT WE DO
OUR RESEARCH POSITION

You need to generate evidence based on more than just having access to large or complex data. We recognize that data is the engine, but it is fueled by knowledge, perspective, rigor and tailored approaches. That’s where we can help you do more with your research questions. Our experts are deeply knowledgeable across a range of therapeutic areas and research methods. Our relationships provide your team with access to specialized expertise and partnerships. These combined strengths fuel our ability to access, understand, integrate and analyze data in ways other can’t. We can help you conduct studies prospectively that will impact future care, and we can look at retrospective data to identify what is driving your questions today. In combination, you can tell a more complete story to meet your needs.

Highlights
check_circle_outline
Relationships
Our teams have expertise across a range of therapeutic areas from complex and chronic to rare and orphan diseases.
check_circle_outline
Expertise
We build strong teams by bringing together the right specialized expertise for your project.
check_circle_outline
Unparalleled Data
Our experienced researchers can do more with large, complex, and linked data assets.
THOUGHT LEADERSHIP
Life Sciences
HEOR Trends: Real-World Evidence and Value-Driven Healthcare

As real-world evidence is increasingly used to inform healthcare decision making, including regulatory decisions, robust methodology is becoming ever more critical.

Life Sciences
The Power of Machine Learning

Machine learning combines advanced statistical methods with the results from validation studies to construct new case-identifying algorithms. We have found these methods to offer marked improvement in the accuracy with which we can identify patients of interest. These methods not...

Life Sciences
Changing the Clinical Trial Paradigm for Rare and Orphan (R&O) Diseases using Real-World Evidence

Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Flora Sandra Siami, MPH, Vice President of Clinical Research, Regulatory Affairs, and Quality Assurance at HealthCore.

Contact us for more information
on our Life Sciences services.